A new study on Chile's national COVID-19 vaccination program, to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon 23-26), and published in The Lancet Global Health, shows that giving a different type of vaccine (heterologous) for the third or 'booster' dose than was received for the first two doses, leads to better vaccine performance than using the same (homologous) inactivated SARS-CoV-2 vaccine for all three doses.
Research of Covid vaccination reveals that mix-and-match approach to booster vaccination offers best protection miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
The researchers found that the level of protection from SARS-CoV-2 infection fell by about 21 percentage points, on average, in the interval from one to six mon
Review of pre-Omicron data reveals Covid vaccine protection from severe disease remains strong at six months miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
After Criticism in Thailand, China Inflates Sinovac s Efficacy polygraph.info - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from polygraph.info Daily Mail and Mail on Sunday newspapers.